v3.25.2
Annual Fund Operating Expenses - Women in Leadership U.S. Equity Portfolio
Oct. 31, 2024
Equity Portfolios - Advisor Classes  
Prospectus [Line Items]  
Fee Waiver or Reimbursement over Assets, Date of Termination Sep. 02, 2026
Equity Portfolios - Advisor Classes | Women in Leadership U.S. Equity Portfolio  
Prospectus [Line Items]  
Management Fees (as a percentage of Assets) 0.55%
Other Expenses (as a percentage of Assets): 0.66%
Expenses (as a percentage of Assets) 1.21%
Fee Waiver or Reimbursement 0.36% [1]
Net Expenses (as a percentage of Assets) 0.85%
Equity Portfolios - Institutional Classes  
Prospectus [Line Items]  
Fee Waiver or Reimbursement over Assets, Date of Termination Sep. 02, 2026
Equity Portfolios - Institutional Classes | Women in Leadership U.S. Equity Portfolio - Institutional Shares  
Prospectus [Line Items]  
Management Fees (as a percentage of Assets) 0.55%
Other Expenses (as a percentage of Assets): 0.46%
Expenses (as a percentage of Assets) 1.01%
Fee Waiver or Reimbursement 0.36% [2]
Net Expenses (as a percentage of Assets) 0.65%
[1] Glenmede Investment Management LP (the “Advisor”) has contractually agreed to waive its fees and/or reimburse expenses to the extent that the Portfolio’s annual total operating expenses exceed 0.85% of the Portfolio’s Advisor Shares’ average daily net assets (excluding Acquired Fund fees and expenses, brokerage commissions, extraordinary items, interest and taxes). The Advisor has contractually agreed to these waivers and/or reimbursements until at least September 2, 2026 and may discontinue this arrangement at any time thereafter. This contractual fee waiver agreement may not be terminated before September 2, 2026 without the approval of The Glenmede Fund, Inc.’s (the “Fund”) Board of Directors (the “Board”).
[2] Glenmede Investment Management LP (the “Advisor”) has contractually agreed to waive its fees and/or reimburse expenses to the extent that the Portfolio’s annual total operating expenses exceed 0.65% of the Portfolio’s Institutional Shares’ average daily net assets (excluding Acquired Fund fees and expenses, brokerage commissions, extraordinary items, interest and taxes). The Advisor has contractually agreed to these waivers and/or reimbursements until at least September 2, 2026 and may discontinue this arrangement at any time thereafter. This contractual fee waiver agreement may not be terminated before September 2, 2026 without the approval of The Glenmede Fund, Inc.’s (the “Fund”) Board of Directors (the “Board”).